PURISYS
Live / Registered — Registered (as of 20 Jan 2026)
What this means for you
Registered since 20 Jan 2026. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88623475
- Registration number
- 8111248
- Mark type
- Stylized text
- Filed
- 19 Sept 2019
- Published for opposition
- 11 Aug 2020
- Registered
- 20 Jan 2026
- Attorney of record
- Mary Grace Gallagher
Goods and services
- Class 001 — Chemicals: Active chemical ingredients for use in the manufacture of pharmaceuticals for treating physical and mental disorders in the nature of epilepsy, convulsions, seizures, nerve damage, pain, chronic pain, inflammation, acne, psoriasis, heart disease, hypertension, coronary artery disease (atherosclerosis), muscle disorders, muscle spasms, bone deficiency, Parkinson disease, Crohn disease, multiple sclerosis, immune disorders, fungal infections, bacterial infections, nausea, vomiting, appetite loss, small intestine disorders, diabetes, high blood sugar, cancer and side effects from the treatment of cancer, Huntington disease, symptoms of withdrawal, temporomandibular disorders, insomnia, trouble sleeping, anxiety, depression, schizophrenia, and bipolar disorder
Owner
- PURISYS LLC, ATHENS, GA, US
- PURISYS LLC, ATHENS, GA, US
- PURISYS LLC, ATHENS, GA, US
- Noramco, Inc., Wilmington, DE, US
Prosecution history
- 20 Jan 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 20 Jan 2026 — REGISTERED-PRINCIPAL REGISTER
- 30 Dec 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 30 Dec 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 26 Jul 2022 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 25 Jul 2022 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 25 Jul 2022 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 22 Jul 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 22 Jul 2022 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 22 Jul 2022 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 22 Jul 2022 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 24 Jan 2022 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 24 Jan 2022 — NON-FINAL ACTION E-MAILED
- 24 Jan 2022 — SU - NON-FINAL ACTION - WRITTEN
- 15 Dec 2021 — ASSIGNED TO EXAMINER